Sagefield Capital’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
Sagefield Capital's ABUS Position: Q3 2026 in Review
Sagefield Capital opened a new position in Arbutus Biopharma (ABUS) in Q3 2026: 1,191,805 shares worth $5.7M. The stake represents 0.47% of the portfolio and ranks #72 among its holdings.
216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- Sagefield Capital held 1,191,805 shares of Arbutus Biopharma worth $5.7M as of Q3 2026.
- Arbutus Biopharma was a new Sagefield Capital position in Q3 2026.
- Arbutus Biopharma made up 0.47% of Sagefield Capital's portfolio in Q3 2026, its #72 holding.
- 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on Sagefield Capital's 13F filing for Q3 2026, filed 16 Nov 2026.